Afya Limited (AFYA) 株式分析

企業概要

Afya Limited operates as a medical education group within the Brazilian market, delivering services primarily through its undergraduate, continuing education, and medical practice solutions segments. The company is classified under the Consumer Defensive sector, specifically within the Education & Training Services industry, a classification that typically suggests resilience against economic downturns due to the essential nature of healthcare training. With a market capitalization of $1.37B and annual revenue of $3.70B, Afya Limited represents a significant entity in its niche, though specific employee count data is not publicly disclosed in the current dataset. The substantial revenue figure relative to its market cap indicates a highly profitable business model where the company generates significant earnings per dollar of market value, suggesting a mature operational structure with strong pricing power or cost efficiencies in the medical education landscape.

財務健全性

The company reported a revenue of $3.70B and net income of $752.46M over the trailing twelve months, with EBITDA reaching $1.47B, highlighting a robust operational earnings base before interest and taxes. The gap between the $3.70B revenue and the $752.46M net income, resulting in a profit margin of 20.4%, reveals a cost structure that successfully converts a significant portion of top-line sales into bottom-line profit while maintaining an operating margin of 30.7%. The firm generated free cash flow of $408.43M, which provides the necessary financial flexibility to service its debt obligations, fund operations, and potentially return capital to shareholders without compromising liquidity. In terms of liquidity management, Afya Limited holds cash of $1.13B against total debt of $3.12B, resulting in a debt-to-equity ratio of 63.79, which indicates a leveraged balance sheet typical of capital-intensive or high-growth service sectors. Despite the leverage, the current ratio stands at 2.20, indicating a conservative short-term liquidity position where current assets are more than double current liabilities, ensuring the ability to meet immediate obligations. Management effectiveness is further evidenced by a Return on Equity of 16.7% and a Return on Assets of 8.4%, metrics that demonstrate the efficient generation of profit from both shareholder equity and total asset base.

バリュエーション評価

The stock currently trades with a P/E Ratio of 9.52 on a trailing twelve-month basis and a forward P/E of 7.17, implying that the market expects earnings growth that will compress the valuation multiple in the coming periods. The price-to-book ratio is recorded at 1.45, suggesting that the market values the company at a moderate premium of approximately 45% over its book value, reflecting intangible assets or growth prospects inherent in the education services sector. Alternative valuation metrics such as the price-to-sales ratio of 0.37 and the EV/EBITDA of 2.32 indicate a low multiple relative to sales and earnings, which often characterizes defensive stocks or companies with high cash flow generation capabilities. Price metrics show a 52-week high of $19.90 and a 52-week low of $13.00; assuming the current trading price aligns with recent market data implied by the P/E ratios, the stock is trading in the upper portion of its recent range, specifically above the midpoint of the $13.00 to $19.90 spread. With a beta of 0.51, Afya Limited exhibits low price volatility relative to the broader market, making it an attractive option for portfolios seeking stability during periods of market turbulence.

Growth & Income

Afya Limited demonstrated a revenue growth of 7.5% year-over-year and earnings growth of 15.2% year-over-year, indicating that earnings are expanding at a significantly faster pace than top-line revenue, which often points to improving operating leverage or margin expansion. As a dividend payer, the company offers a dividend yield of 4.3% with a payout ratio of 16.2%, a conservative level that suggests the dividend is highly sustainable given the robust net income generation and low payout commitment relative to earnings. The low payout ratio allows the company to retain a substantial portion of its profits to reinvest in the medical education curriculum, technology, and facility expansion rather than distributing all earnings as cash. Overall, the growth and income profile is characterized by accelerating earnings growth supported by a defensive dividend yield and a balance sheet capable of sustaining this payout structure without excessive leverage risk.